BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31496179)

  • 1. [Not Available].
    Nau JY
    Rev Med Suisse; 2019 Aug; 15(660):1526-1527. PubMed ID: 31496179
    [No Abstract]   [Full Text] [Related]  

  • 2. [Self-sampling at home can prevent cervix cancer].
    Sanner K; Wikström I; Lindell M; Strand A; Wilander E
    Lakartidningen; 2009 Nov 11-17; 106(46):3075-7. PubMed ID: 19998610
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is the HPV test to supplement vaginal smears in menopausal women?].
    Gustavsson I; Gyllensten U; Lindell M; Wilander E
    Lakartidningen; 2010 Feb 24-Mar 2; 107(8):528-9. PubMed ID: 20384066
    [No Abstract]   [Full Text] [Related]  

  • 4. New HPV test now recommended.
    AIDS Patient Care STDS; 2003 Dec; 17(12):671-2. PubMed ID: 14748367
    [No Abstract]   [Full Text] [Related]  

  • 5. Human papillomavirus in carcinogenesis of cervical cancer.
    de Silva NR; Mendis L; Perera N
    Ceylon Med J; 1999 Mar; 44(1):45-7. PubMed ID: 10643100
    [No Abstract]   [Full Text] [Related]  

  • 6. [HPV infection of the cervix and capabilities of advanced diagnostics].
    Akush Ginekol (Sofiia); 2010; 49(3):40-3. PubMed ID: 20734655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attention-getting sexually transmitted diseases: Human papillomavirus infections].
    Matsumoto K; Yoshikawa H
    Nihon Naika Gakkai Zasshi; 2007 Nov; 96(11):2456-64. PubMed ID: 18069298
    [No Abstract]   [Full Text] [Related]  

  • 8. The Impact and Burden of Human Papillomavirus-Associated Disease.
    Ducatman BS
    Arch Pathol Lab Med; 2018 Jun; 142(6):686-687. PubMed ID: 29848033
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia.
    Schiffman MH; Castle P
    J Natl Cancer Inst; 2003 Mar; 95(6):E2. PubMed ID: 12644550
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular characterization of human papillomaviruses by PCR and in situ hybridization.
    Vernon SD; Unger ER
    Methods Mol Med; 2004; 97():159-80. PubMed ID: 15064492
    [No Abstract]   [Full Text] [Related]  

  • 11. Human papillomavirus genotypes in invasive cervical cancer in Jordan.
    Sughayer MA; Abdelhadi M; Abdeen G; Otay L; Dayeh T
    Int J Gynaecol Obstet; 2010 Jan; 108(1):74-5. PubMed ID: 19892334
    [No Abstract]   [Full Text] [Related]  

  • 12. HPV infection among Uygur women in a rural area of Hetian Prefecture, Xinjiang Uygur Autonomous Region, China.
    Husaiyin S; Niyazi M; Wang Lh; Wang JJ; Wang JB; Simayi A; Wang L; Ainiwaer Z; Ma CH; Smith JS
    Biomed Environ Sci; 2013 Nov; 26(11):934-6. PubMed ID: 24331541
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluating the impact of HPV-related diseases: cervical cancer and genital warts.
    Brotzman GL
    J Fam Pract; 2005 Jul; Suppl HPV Prevention():S3-9; quiz S23. PubMed ID: 16093010
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient safety and the next generation of HPV DNA tests.
    Lee SH
    Am J Clin Pathol; 2011 Mar; 135(3):481; author reply 482-3. PubMed ID: 21350106
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer.
    zur Hausen H
    J Natl Cancer Inst; 2001 Feb; 93(4):252-3. PubMed ID: 11181763
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections.
    Kaufman HW; Hilborne LH; Alagia DP
    Obstet Gynecol; 2018 Sep; 132(3):778. PubMed ID: 30134394
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections.
    Dhar JP; Sokol RJ
    Obstet Gynecol; 2018 Sep; 132(3):777-778. PubMed ID: 30134393
    [No Abstract]   [Full Text] [Related]  

  • 18. Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections.
    Austin RM; Zhao C; Mody DR
    Obstet Gynecol; 2018 Sep; 132(3):777. PubMed ID: 30134392
    [No Abstract]   [Full Text] [Related]  

  • 19. [HPV testing and cervical cancer screening. Evidences, resistances and current practices].
    Monsonego J
    Gynecol Obstet Fertil; 2012 May; 40(5):269-72. PubMed ID: 22521159
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections.
    Schiffman M; Huh WK; Stockdale CK; Einstein MH; Chelmow D; Flowers LC
    Obstet Gynecol; 2018 Sep; 132(3):778-779. PubMed ID: 30134395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.